Two-year durability of MVA-BN vaccine-induced antibodies and the risk of Mpox breakthrough infections among high-risk populations: a prospective, longitudinal study

Clinical Microbiology and Infection · Published 2026-08-01 · DOI 10.1016/j.cmi.2026.07.048

Free full text

Authors (26)

Wang-Da Liu, Ut Man Chan, Tai-Ling Chao, Kai-Hsiang Chen, Hsin-Yun Sun, Kuan-Yin Lin, Yu-Shan Huang, Chi-Ying Lin, Ming-Chieh Shih, Guei-Chi Li, Wen-Chun Liu, Cheng-Hsin Wu, Yi-Ching Su, Chia-Yi Lin, Chih-Hao Hung, Ling-Ya Chen, Yu-Zhen Luo, Hsi-Yen Chang, Pei-Ying Wu, Yi-Ting Chen, Ting-Kai Wang, Wang-Huei Sheng, Szu-Min Hsieh, Shih-Chung Chang, Sui-Yuan Chang, Chien-Ching Hung

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Liu, W., Chan, U., Chao, T., et al. (2026). Two-year durability of MVA-BN vaccine-induced antibodies and the risk of Mpox breakthrough infections among high-risk populations: a prospective, longitudinal study. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2026.07.048

Related articles